It is time to stop ignoring malignancy in heart transplantation: A call to arms

被引：23

作者：

Hauptman, PJ

Mehra, MR

机构：

[1] St Louis Univ, Hlth Sci Ctr, St Louis, MO USA

[2] Alton Ochsner Med Fdn & Ochsner Clin, New Orleans, LA 70121 USA

来源：

JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2005年 / 24卷 / 08期

关键词：

D O I：

10.1016/j.healun.2004.06.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Increasing numbers of patients are surviving more than 5 years after heart transplantation. Despite the dramatic nature of coronary allograft vasculopathy, Cardiac Transplant Research Database data have shown, and International Society for Heart and Lung Transplantation Registry data suggest, that malignancy is the leading cause of death among long-term survivors of heart transplantation. Recommendations on malignancy screening are provided as well as an outline of areas of ongoing uncertainty.

引用

页码：1111 / 1113

页数：3

共 25 条

[1] Tacrolimus monotherapy in adult cardiac transplant recipients: Intermediate-term results [J].

Baran, DA ;

Segura, L ;

Kushwaha, S ;

Courtney, M ;

Correa, R ;

Fallon, JT ;

Cheng, J ;

Lansman, SL ;

Gass, AL .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (01) :59-70

[2] Transmission of donor cancer into cardiothoracic transplant recipients [J].

Buell, JF ;

Trofe, J ;

Hanaway, MJ ;

Lo, A ;

Rosengard, B ;

Rilo, H ;

Alloway, R ;

Beebe, T ;

First, MR ;

Woodle, ES .

SURGERY, 2001, 130 (04) :660-666

[3]

Czarnik BT, 2001, CIRCULATION, V104, P646

[4] Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients [J].

Eisen, HJ ;

Tuzcu, EM ;

Dorent, R ;

Kobashigawa, J ;

Mancini, D ;

Valantine-von Kaeppler, HA ;

Starling, RC ;

Sorensen, K ;

Hummel, M ;

Lind, JM ;

Abeywickrama, KH ;

Bernhardt, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (09) :847-858

[5]

HAUPTMAN PJ, 1995, J HEART LUNG TRANSPL, V14, P654

[6] The Registry of the International Society for Heart and Lung Transplantation: Eighteenth official report-2001 [J].

Hosenpud, JD ;

Bennett, LE ;

Keck, BM ;

Boucek, MM ;

Novick, RJ .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (08) :805-815

[7] Myelodysplastic syndrome and acute myelogenous leukemia secondary to heart transplantation [J].

Huebner, G ;

Karthaus, M ;

Pethig, K ;

Freund, M ;

Ganser, A .

TRANSPLANTATION, 2000, 70 (04) :688-690

[8] Evolving trends in risk profiles and causes of death after heart transplantation: A ten-year multi-institutional study [J].

Kirklin, JK ;

Naftel, DC ;

Bourge, RC ;

McGiffin, DC ;

Hill, JA ;

Rodeheffer, RJ ;

Jaski, BE ;

Hauptman, PJ ;

Weston, M ;

White-Williams, C .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (04) :881-890

[9]

Kobashigawa J. K., 2004, Journal of Heart and Lung Transplantation, V23, pS51, DOI 10.1016/j.healun.2003.11.028

[10] EFFECT OF PRAVASTATIN ON OUTCOMES AFTER CARDIAC TRANSPLANTATION [J].

KOBASHIGAWA, JA ;

KATZNELSON, S ;

LAKS, H ;

JOHNSON, JA ;

YEATMAN, L ;

WANG, XM ;

CHIA, D ;

TERASAKI, PI ;

SABAD, A ;

COGERT, GA ;

TROSIAN, K ;

HAMILTON, MA ;

MORIGUCHI, JD ;

KAWATA, N ;

HAGE, A ;

DRINKWATER, DC ;

STEVENSON, LW .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (10) :621-627

← 1 2 3 →